Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced...
Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature
About this item
Full title
Author / Creator
Hu, Shaobo , Wang, Xianhua , Su, Fei , Zhou, Qiong , Li, Zhaoqing , Luo, Jie and Tan, Huangying
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Ectopic adrenocorticotropic hormone syndrome (EAS) is a rare condition caused by pancreatic neuroendocrine tumors (p-NETs). The severe hypercortisolemia that characterizes EAS is associated with a poor prognosis and survival. Mitotane is the only adrenolytic drug approved by the Food and Drug Administration and is often used to treat adrenocortical...
Alternative Titles
Full title
Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f8e48ff13e434d2497c3cd2e088d6fec
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f8e48ff13e434d2497c3cd2e088d6fec
Other Identifiers
ISSN
0300-0605
E-ISSN
1473-2300
DOI
10.1177/03000605231220867